TOPRA Offers New European Regulatory Affairs Course
TOPRA is offering a new European regulatory affairs course this month in Philadelphia and San Diego:
Philadelphia course date: April 19, 2010.
San Diego course date: April 23, 2010.
Target audience – Regulatory professionals and support staff in Regulatory Affairs and other related areas such as Medical, Manufacturing, Marketing etc. with a need to know European Regulatory Affairs. Suitable for staff in agencies and companies.
This is a new course, where you will have the opportunity to learn about European Regulatory Affairs direct from the source. These courses are limited to 30 attendees to ensure a relaxed informal environment with plenty of opportunity for interaction with the speakers.
The purpose of the day
The European Regulatory systems can be confusing and complex particularly for those not based in the European Union. The purpose of this course is to provide you with a clear and concise understanding of the European Regulatory environment including an overview of the key regulatory processes and procedures.
What you will learn
European Institutions and the European Legislative framework
European Clinical Trial Processes and Procedures
European Marketing Authorisation Processes and Procedures
The European system for classification of Post Approval Amendments
(Variations) and associated procedures.
Advertising, Labelling and Leaflets in the European Union
$400 - delegates will also receive free TOPRA membership until 1 January 2011 (Regulatory Rapporteur and InTouch Online only.)
Timings are 10 a.m. - 4 p.m. with breaks for morning coffee and lunch.
Venue:
Philadelphia, PA and San Diego, CA
Address:
Philadelphia, PA and San Diego, CA
Click here to register.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Regulatory Compliance With eCOAs
April 26th 2024In the fourth and final part of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA discusses how the regulatory stance on electronic clinical outcome assessments has changed over the years and what it could look like in the future.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
